The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Open accessAbstract
While the catalog of mammalian transcripts and their expression levels in different cell types and disease states is rapidly expanding, our understanding of transcript function lags behind. We present a robust technology enabling systematic investigation of the cellular consequences of repressing or inducing individual transcripts. We identify rules for specific targeting of transcriptional repressors (CRISPRi), typically achieving 90%-99% knockdown with minimal off-target effects, and activators (CRISPRa) to endogenous genes via endonuclease-deficient Cas9. Together they enable modulation of gene expression over a ∼1,000-fold range. Using these rules, we construct genome-scale CRISPRi and CRISPRa libraries, each of which we validate with two pooled screens. Growth-based screens identify essential genes, tumor suppressors, and regulators of differentiation. Screens for sensitivity to a cholera-diphtheria toxin provide broad insights into the mechanisms of pathogen entry, retrotranslocation and toxicity. Our results establish CRISPRi and CRISPRa as powerful tools that provide rich and complementary information for mapping complex pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with gain-of-function perturbations, a higher proportion of loss-of-function perturbations yield phenotypes in growth and chemical-genetic screens, especially for members of protein complexes (Gilbert et al., 2014; Horlbeck et al., 2016).”
From Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq (2022) · cites this paper as Gilbert et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, CRISPRi (interference)23–25 and CRISPRa (activation)26–30 technologies utilize catalytically inactive Cas9 (dCas9) fused to either a transcriptional repressor (e.g., KRAB, Krüppel associated box) or a transcriptional activator (e.g., VPR, VP64-p65-Rta).”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“Pooling gene perturbations greatly improves scalability, but is not compatible with imaging of complex and dynamic cellular phenotypes.”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Gilbert et al., 2014
In the citing paper
“Striking examples are familial mutations causing neurodegenerative diseases, such as hereditary motor and sensory neuropathies (Charcot-Marie-Tooth disease), which can be caused by mutations in ubiquitously expressed trafficking factors (RAB7A, DNM2, DYNC1H1), or aminoacyl-tRNA synthetases (AARS, GARS, HARS, MARS)2.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [2]
In the citing paper
“In addition to gene expression, gene function can also be cell type-specific, as evidenced by the fact that mutations in broadly expressed or housekeeping genes can lead to cell-type specific defects and disease states.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [2]
In the citing paper
“CRISPRa evaluates gain-of-function phenotypes and can provide complementary insight to CRISPR knockout or CRISPRi-based loss-of-function screens42.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [42]
In the citing paper
“CRISPRi-based gene knockdown may result in weaker phenotypes than full gene knockout, however it is non-toxic in iPSCs and iPSC-derived cells76, inducible76 and reversible42, thereby enabling time-resolved analysis of gene function76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [42]
In the citing paper
“CRISPRi represents an important advance over RNAi, since it lacks the pervasive off-target effects (Gilbert et al., 2014) inherent to RNAi-based screening approaches (Adamson et al., 2012; Jackson et al., 2003; Kaelin, 2012).”
From CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons (2019) · cites this paper as Gilbert et al., 2014
In the citing paper
“Second, it is inducible and reversible (Gilbert et al., 2014)”
From CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons (2019) · cites this paper as Gilbert et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Derrien, T., Johnson, R., Bussotti, G., Andrea Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., et al. (2012) · Genome Research · doi:10.1101/gr.132159.111 · Cited by 5,135
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,008
Vázquez‐Vilar, M., Quijano‐Rubio, A., Fernández‐del‐Carmen, A., Sarrion‐Perdigones, A., Ochoa‐Fernandez, R., Ziarsolo, P., Blanca, J., Granell, A., & Orzáez, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1326 · Cited by 99
Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine
Sioson, V. A., Kim, M., & Joo, J. (2021) · Biomedical Engineering Letters · doi:10.1007/s13534-021-00199-4 · Cited by 120
Functional single-cell genomics of human cytomegalovirus infection
Hein, M. Y., & Weissman, J. S. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01059-3 · Cited by 97
Self-citationChung, J. Y., Ain, Q. U., Song, Y., Yong, S., & Kim, Y. (2019) · Genome Research · doi:10.1101/gr.246900.118 · Cited by 102
Functional Genomics via CRISPR–Cas
Ford, K. M., McDonald, D., & Mali, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.034 · Cited by 103
Nakamura, K., Kustatscher, G., Alabert, C., Hödl, M., Forné, I., Völker-Albert, M. C., Satpathy, S., Beyer, T. E., Mailand, N., Choudhary, C., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.025 · Cited by 99
CRISPR/Cas System and Factors Affecting Its Precision and Efficiency
Javaid, N., & Choi, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.761709 · Cited by 106
A universal deep-learning model for zinc finger design enables transcription factor reprogramming
Ichikawa, D. M., Abdin, O., Alerasool, N., Kogenaru, M., Mueller, A. L., Wen, H., Giganti, D. O., Goldberg, G. W., Adams, S., Spencer, J. M., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01624-4 · Cited by 101
Genetic screens and functional genomics using CRISPR /Cas9 technology
Hartenian, E., & Doench, J. G. (2015) · FEBS Journal · doi:10.1111/febs.13248 · Cited by 100
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology
Tian, X., Gu, T., Patel, S., Bode, A. M., Lee, M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0080-7 · Cited by 105
Wang, Q., & Coleman, J. J. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.007 · Cited by 103
Inference of transcriptional regulation in cancers
Jiang, P., Freedman, M. L., Liu, J. S., & Liu, X. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424272112 · Cited by 93
Next-generation libraries for robust RNA interference-based genome-wide screens
Kampmann, M., Horlbeck, M. A., Chen, Y., Tsai, J. C., Bassik, M. C., Gilbert, L. A., Villalta, J. E., Kwon, S. C., Chang, H., Kim, V. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508821112 · Cited by 96
Self-citationSingle-cell and multivariate approaches in genetic perturbation screens
Liberali, P., Snijder, B., & Pelkmans, L. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3768 · Cited by 94
CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges
Yi, L., & Li, J. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.002 · Cited by 96
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
Oakes, B. L., Fellmann, C., Rishi, H. S., Taylor, K. L., Ren, S. M., Nadler, D. C., Yokoo, R., Arkin, A. P., Doudna, J. A., & Savage, D. F. (2019) · Cell · doi:10.1016/j.cell.2018.11.052 · Cited by 94
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma
Syafruddin, S. E., Rodrigues, P., Vojtasova, E., Patel, S. A., Zaini, M. N., Burge, J., Warren, A. Y., Stewart, G. D., Eisen, T. G., Bihary, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09116-x · Cited by 97
Tadić, V., Josipović, G., Zoldoš, V., & Vojta, A. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.003 · Cited by 99
Zhang, S., Guo, F., Yan, W., Dai, Z., Dong, W., Zhou, J., Zhang, W., Xin, F., & Jiang, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00459 · Cited by 95
CRISPR screens for functional interrogation of immunity
Shi, H., Doench, J. G., & Chi, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00802-4 · Cited by 102
Virtual Cell Challenge: Toward a Turing test for the virtual cell
Roohani, Y., Hua, T. J., Tung, P., Bounds, L. R., Yu, F. B., Dobin, A., Teyssier, N., Adduri, A., Woodrow, A., Plosky, B. S., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.008 · Cited by 118
Self-citationNanoparticle-based autoimmune disease therapy
Serra, P., & Santamaría, P. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.02.003 · Cited by 94
Ng, H., & Dean, N. (2017) · mSphere · doi:10.1128/msphere.00385-16 · Cited by 94
PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens
Lenoir, W. F., Lim, T. L., & Hart, T. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx993 · Cited by 94
Improved sgRNA design in bacteria via genome-wide activity profiling
Guo, J., Wang, T., Guan, C., Liu, B., Luo, C. Y., Xie, Z., Zhang, C., & Xing, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky572 · Cited by 99
Epigenome engineering: new technologies for precision medicine
Sgro, A., & Blancafort, P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1000 · Cited by 96
Synthetic Biology in Natural Product Biosynthesis
Seshadri, K., Abad, A. N. D., Nagasawa, K. K., Yost, K. M., Johnson, C. W., Dror, M. J., & Tang, Y. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00567 · Cited by 94
Human evolution: the non-coding revolution
Franchini, L. F., & Pollard, K. S. (2017) · BMC Biology · doi:10.1186/s12915-017-0428-9 · Cited by 90
Chromatin-enriched lncRNAs can act as cell-type specific activators of proximal gene transcription
Werner, M. S., Sullivan, M. A., Shah, R. N., Nadadur, R. D., Grzybowski, A. T., Galat, V., Moskowitz, I. P. G., & Ruthenburg, A. J. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3424 · Cited by 96
Wen, Z., Ledesma‐Amaro, R., Lin, J., Jiang, Y., & Yang, S. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.02560-18 · Cited by 94
Genga, R. M. J., Kernfeld, E. M., Parsi, K. M., Parsons, T. J., Ziller, M. J., & Maehr, R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.076 · Cited by 92
Structural and mechanistic basis of the EMC-dependent biogenesis of distinct transmembrane clients
Miller-Vedam, L. E., Bräuning, B., Popova, K. D., Schirle Oakdale, N. T., Bonnar, J. L., Prabu, J. R., Boydston, E. A., Sevillano, N., Shurtleff, M. J., Stroud, R. M., et al. (2020) · eLife · doi:10.7554/elife.62611 · Cited by 87
Self-citationChemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering
Nuñez, J. K., Harrington, L. B., & Doudna, J. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01019 · Cited by 92
Guide RNAs with embedded barcodes boost CRISPR-pooled screens
Zhu, S., Cao, Z., Liu, Z., He, Y. M., Wang, Y., Yuan, P., Li, W., Tian, F., Bao, Y., & Wei, W. (2019) · Genome biology · doi:10.1186/s13059-019-1628-0 · Cited by 89
Zhu, H., & Liang, C. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty1061 · Cited by 88
Review of high-content screening applications in toxicology
Li, S., & Xia, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02593-5 · Cited by 99
Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease
Guhathakurta, S., Kim, J.-I., Adams, L., Basu, S., Song, M. K., Adler, E. R., Je, G., Fiadeiro, M. B., & Kim, Y. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012188 · Cited by 95
Applications of the versatile CRISPR‐Cas13 RNA targeting system
Kordyś, M., Sen, R., & Warkocki, Z. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1694 · Cited by 97
John van der, O. O. S. T., & Patinios, C. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.12.022 · Cited by 102
Martinko, A. J., Truillet, C., Julien, O., Diaz, J. E., Horlbeck, M. A., Whiteley, G., Blonder, J., Weissman, J. S., Bandyopadhyay, S., Evans, M. J., et al. (2018) · eLife · doi:10.7554/elife.31098 · Cited by 91
Self-citationCRISPR library designer (CLD): software for multispecies design of single guide RNA libraries
Heigwer, F., Zhan, T., Breinig, M., Winter, J., Brügemann, D., Leible, S., & Boutros, M. (2016) · Genome biology · doi:10.1186/s13059-016-0915-2 · Cited by 92
Transcription control engineering and applications in synthetic biology
Engstrom, M. D., & Pfleger, B. F. (2017) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2017.09.003 · Cited by 96
Alda-Catalinas, C., Bredikhin, D., Hernando-Herraez, I., Santos, F., Kubinyecz, O., Eckersley-Maslin, M. A., Stegle, O., & Reik, W. (2020) · Cell Systems · doi:10.1016/j.cels.2020.06.004 · Cited by 88
CRISPR/Cas9 Landscape: Current State and Future Perspectives
Tyumentsev, A. I., Tyumentsev, A. I., & Акимкин, В. Г. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216077 · Cited by 98
Deciphering the impact of genomic variation on function
Writing group (ordered by contribution), Engreitz, J., Lawson, H. A., Singh, H., Starita, L. M., Hon, G. C., Carter, H. K., Sahni, N., Reddy, T. E., Lin, X., et al. (2024) · Nature · doi:10.1038/s41586-024-07510-0 · Cited by 105
Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers
Aguirre, A. J., & Hahn, W. C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031518 · Cited by 90
Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications
Didovyk, A., Borek, B., Tsimring, L., & Hasty, J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.06.003 · Cited by 90
Genome editing in cardiovascular diseases
Strong, A., & Musunuru, K. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.139 · Cited by 91
The role of long non-coding RNAs in rheumatic diseases
Tang, Y., Zhou, T., Yu, X., Xue, Z., & Shen, N. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.162 · Cited by 90
Togami, K., Pastika, T. J., Stephansky, J., Ghandi, M., Christie, A. L., Jones, K. L., Johnson, C. A., Lindsay, R. W. B., Brooks, C. L., Letai, A. G., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128571 · Cited by 91
Collateral activity of the CRISPR/RfxCas13d system in human cells
Shi, P., Murphy, M. R., Aparicio, A. O., Kesner, J. S., Fang, Z., Chen, Z., Trehan, A., Guo, Y., & Wu, X. (2023) · Communications Biology · doi:10.1038/s42003-023-04708-2 · Cited by 91
Cas9, Cpf1 and C2c1/2/3―What's next?
Nakade, S., Yamamoto, T., & Sakuma, T. (2017) · Bioengineered · doi:10.1080/21655979.2017.1282018 · Cited by 92
Farhang, N., Brunger, J. M., Stover, J. D., Thakore, P. I., Lawrence, B. D., Guilak, F., Gersbach, C. A., Setton, L. A., & Bowles, R. D. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0441 · Cited by 90
Cao, Y., Li, X., Li, F., & Song, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00374 · Cited by 89
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
Chan, Y.-T., Lu, Y., Wu, J., Zhang, C., Tan, H., Bian, Z., Wang, N., & Feng, Y. (2022) · Theranostics · doi:10.7150/thno.71144 · Cited by 93
Network-based approaches for analysis of complex biological systems
Chasman, D. A., Siahpirani, A. F., & Roy, S. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.04.007 · Cited by 89
CRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
Self-citationWang, S., Jin, J., Xu, Z., & Zuo, B. (2019) · Cells · doi:10.3390/cells8091107 · Cited by 89
Naduthodi, M. I. S., Südfeld, C., Avitzigiannis, E. K., Trevisan, N., van Lith, E., Sancho, J. A., D’Adamo, S., Barbosa, M. J., & John van der, O. O. S. T. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00329 · Cited by 89
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Awwad, S. W., Serrano-Benítez, A., Thomas, J. C., Gupta, V., & Jackson, S. P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00571-x · Cited by 93
Efficient genome engineering approaches for the short-lived African turquoise killifish
Harel, I., Valenzano, D. R., & Brunet, A. (2016) · Nature Protocols · doi:10.1038/nprot.2016.103 · Cited by 89
CRISPR-Cas based antiviral strategies against HIV-1
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2017) · Virus Research · doi:10.1016/j.virusres.2017.07.020 · Cited by 86
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Chen, Y., & Zhang, Y. (2018) · Advanced Science · doi:10.1002/advs.201700964 · Cited by 91
Self-citationCentromere and Pericentromere Transcription: Roles and Regulation … in Sickness and in Health
Smurova, K., & Wulf, P. D. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00674 · Cited by 86
Mapping human cell phenotypes to genotypes with single-cell genomics
Camp, J. G., Platt, R. J., & Treutlein, B. (2019) · Science · doi:10.1126/science.aax6648 · Cited by 85
STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production
Li, D., Wu, R., Guo, W., Xie, L., Qiao, Z., Chen, S., Zhu, J., Huang, C., Huang, J. A., Chen, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.069 · Cited by 87
High-content imaging-based pooled CRISPR screens in mammalian cells
Yan, X., Stuurman, N., Ribeiro, S. A., Tanenbaum, M. E., Horlbeck, M. A., Liem, C. R., Jost, M., Weissman, J. S., & Vale, R. D. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202008158 · Cited by 83
Self-citationReilly, S. K., Gosai, S. J., Gutierrez, A., Mackay-Smith, A., Ulirsch, J. C., Kanai, M., Mouri, K., Berenzy, D., Kales, S., Butler, G. M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00900-4 · Cited by 86
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence
Cheng, Y., Wang, S., Zhang, H., Lee, J.-S., Ni, C., Guo, J., Chen, E., Wang, S., Acharya, A., Chang, T.-C., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.019 · Cited by 92
Cress, B. F., Jones, J. A., Kim, D. C., Leitz, Q. D., Englaender, J. A., Collins, S. M., Linhardt, R. J., & Koffas, M. A. G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw231 · Cited by 93
Chemically Modified Cpf1-CRISPR RNAs Mediate Efficient Genome Editing in Mammalian Cells
McMahon, M. A., Prakash, T. P., Cleveland, D. W., Bennett, C. F., & Rahdar, M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.031 · Cited by 87
Palos, K. R., Yu, L., Railey, C. E., Dittrich, A. C. N., & Nelson, A. D. L. (2023) · The Plant Cell · doi:10.1093/plcell/koad027 · Cited by 85
Zwick, R. K., Kašpárek, P., Palikuqi, B., Viragova, S., Weichselbaum, L., McGinnis, C. S., McKinley, K. L., Rathnayake, A., Vaka, D., Nguyen, V. Q., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-023-01337-z · Cited by 92
Bailus, B. J., Pyles, B., McAlister, M., O’Geen, H., Lockwood, S. H., Adams, A. N., Nguyen, J. T., Yu, A. S., Berman, R. F., & Segal, D. J. (2016) · Molecular Therapy · doi:10.1038/mt.2015.236 · Cited by 87
Targeted regulation of transcription in primary cells using CRISPRa and CRISPRiPreprint
Jensen, T. I., Mikkelsen, N. S., Gao, Z., Foßelteder, J., Pabst, G., Axelgaard, E., Laustsen, A., König, S., Reinisch, A., & Bak, R. O. (2021) · Genome Research · doi:10.1101/gr.275607.121 · Cited by 92
Ho, S., Hartley, B. J., Flaherty, E. K., Rajarajan, P., Abdelaal, R., Obiorah, I., Barretto, N., Muhammad, H., Phatnani, H. P., Akbarian, S., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.012 · Cited by 82
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
Knight, S. C., Tjian, R., & Doudna, J. A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201709201 · Cited by 86
Hallmarks of cancer: The CRISPR generation
Moses, C., García‐Bloj, B., Harvey, A. R., & Blancafort, P. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.01.002 · Cited by 90
Single-Cell Multi-omics: An Engine for New Quantitative Models of Gene Regulation
Packer, J. S., & Trapnell, C. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.06.001 · Cited by 85
CRISPR/Cas9 screening using unique molecular identifiers
Schmierer, B., Botla, S. K., Zhang, J., Turunen, M. M., Kivioja, T., & Taipale, J. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177834 · Cited by 79
The therapeutic application of CRISPR/Cas9 technologies for HIV
Saayman, S. M., Ali, S. A., Morris, K. V., & Weinberg, M. S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1036736 · Cited by 91
Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments
Canver, M. C., Haeussler, M., Bauer, D. E., Orkin, S. H., Sanjana, N. E., Shalem, O., Yuan, G., Zhang, F., Concordet, J., & Pinello, L. (2018) · Nature Protocols · doi:10.1038/nprot.2018.005 · Cited by 91
Bacterial CRISPR: accomplishments and prospects
Peters, J. M., Silvis, M. R., Zhao, D., Hawkins, J. S., Gross, C. A., & Qi, L. S. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.08.007 · Cited by 88
Self-citationCRISPR: gene editing is just the beginning
Ledford, H. K. (2016) · Nature · doi:10.1038/531156a · Cited by 84
CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects
Paul, J. W., & Qi, Y. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1985-z · Cited by 90
GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens
Rauscher, B., Heigwer, F., Breinig, M., Winter, J., & Boutros, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw997 · Cited by 84
Wangensteen, K. J., Wang, Y. J., Dou, Z., Wang, A. W., Mosleh‐Shirazi, E., Horlbeck, M. A., Gilbert, L. A., Weissman, J. S., Berger, S. L., & Kaestner, K. H. (2017) · Hepatology · doi:10.1002/hep.29626 · Cited by 84
Self-citationYadav, B., Pal, S., Rubstov, Y., Goel, A., Garg, M., Pavlyukov, M. S., & Pandey, A. K. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.03.018 · Cited by 85
Evolution of metastasis: new tools and insights
Gui, P., & Bivona, T. G. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.11.002 · Cited by 85
Recent advances in machine learning applications in metabolic engineering
Patra, P., Disha, B. R., Kundu, P., Das, M., & Ghosh, A. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.108069 · Cited by 90
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation
Parra Bravo, C., Giani, A. M., Madero-Perez, J., Zhao, Z., Wan, Y., Samelson, A. J., Wong, M. Y., Evangelisti, A., Cordes, E., Fan, L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.015 · Cited by 90
Self-citationCRISPR genome engineering and viral gene delivery: A case of mutual attraction
Schmidt, F., & Grimm, D. (2015) · Biotechnology Journal · doi:10.1002/biot.201400529 · Cited by 85
RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
Unniyampurath, U., Pilankatta, R., & Krishnan, M. N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030291 · Cited by 88
Stojic, L., Prater, M., Orjalo, A. V., Ito, Y., Ruijter, A. E. M., Uribe‐Lewis, S., Joseph, N., Weston, S. D., Menon, S., Odom, D. T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10406 · Cited by 84
Ietswaart, R., Smalec, B. M., Xu, A., Choquet, K., McShane, E., Jowhar, Z. M., Guegler, C. K., Baxter-Koenigs, A. R., West, E. R., Fu, B. X. H., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.06.008 · Cited by 83
Self-citationCai, P., Otten, A. B. C., Cheng, B., Ishii, M. A., Zhang, W., Huang, B., Qu, K., & Sun, B. K. (2019) · Genome Research · doi:10.1101/gr.251561.119 · Cited by 83
A CRISPR Screen Identifies LAPTM4A and TM9SF Proteins as Glycolipid-Regulating Factors
Yamaji, T., Sekizuka, T., Tachida, Y., Sakuma, C., Morimoto, K., Kuroda, M., & Hanada, K. (2019) · iScience · doi:10.1016/j.isci.2018.12.039 · Cited by 82
Zheng, X., Wu, B., Liu, Y., Simmons, S., Kim, K., Clarke, G. S., Ashiq, A., Park, J. C., Li, J., Wang, Z., et al. (2024) · Cell · doi:10.1016/j.cell.2024.04.050 · Cited by 86
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease
Doetschman, T., & Georgieva, T. G. (2017) · Circulation Research · doi:10.1161/circresaha.116.309727 · Cited by 91
Big science and big data in nephrology
Sáez-Rodríguez, J., Rinschen, M. M., Floege, J., & Kramann, R. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.048 · Cited by 84
Metadata
- Authors
- Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., Qi, L. S., Kampmann, M., & Weissman, J. S.
- Affiliations
- QB3 (US)
- University of California, San Francisco (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Kampmann, Martin
- Weissman, Jonathan S.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 159
- Issue
- 3
- Pages
- 647-661
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4253859
- OpenAlex
- W2152505144
- Cited by
- 2,728
- References
- 60
- Citations by year
- 2026: 190 · 2025: 211 · 2024: 265 · 2023: 212 · 2022: 261 · 2021: 285 · 2020: 285 · 2019: 255 · 2018: 221 · 2017: 214 · 2016: 182 · 2015: 125 · 2014: 14
- FWCI
- 73.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (DP5OD017887, 1dp2hd084069-01)
- National Institute on Aging (P01AG010770)
- National Institute on Drug Abuse (R01DA036858)
- National Cancer Institute (K99CA181494, U01CA168370)
- National Institute of General Medical Sciences (T32GM008284, P50GM081879, R01GM100341, P50GM102706, R01GM100518)
- National Institute of Biomedical Imaging and Bioengineering (T32EB009383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR interference, CRISPR activation, transcriptional repression, transcriptional activation, gene essentiality, tumor suppressor, cholera toxin, diphtheria toxin, pathogen entry, retrotranslocation, off-target effects
- MeSH terms
- Cell Line, Cholera Toxin, Diphtheria Toxin, Genetic Techniques, Humans, Transcription, Genetic, Genome, Human, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
